Citations

Mayo Clinic

Showing 10 of 108537 citations.

Mammalian hyaluronan synthases and their functions
Itano, Naoki , Yoshida, Mamoru, Yamada, Yoichi , Lenas, Petros, Spicer, Andrew P., McDonald, John A., Kimata, Koji

Biochemical Society Transactions | August 11, 2015 | Volume: 27 | Issue: 1 | Pages: A10-A10

10.1042/bst027a010b Get It

COMPARTMENTALIZATION OF cAMP-PROTEIN KINASE A (PKA) SIGNALING BY ISOZYMES PDE-IV AND PDE-III IN RAT MESANGIAL CELLS
Douša, Thomas P., Chini, Claudio, Chini, Eduardo N. , Tsuboi, Yasushi, Grande, Jorge

Biochemical Society Transactions | August 11, 2015 | Volume: 24 | Issue: 4 | Pages: 580S-580S

10.1042/bst024580sa Get It

Very low density lipoprotein subtraction apolipoprotein composition
Coppack, Simon W., Kottke, Bruce A., MILES, JOHN M., Fisher, Rachel M. , MILES, JOHN M.

Biochemical Society Transactions | August 11, 2015 | Volume: 21 | Issue: 3 | Pages: 231S-231S

10.1042/bst021231s | PMID 8224388 Get It

A case of lymphoproliferative disorder of NK‐cells: aggressive immunophenotype but indolent behavior
Savage, Natasha M. , Salman, Huda , Morice, William G. , Shi, Min , Morice, William George , Salman, Huda

Clinical Case Reports | August 11, 2015 | Volume: 3 | Issue: 9 | Pages: 740-743

10.1002/ccr3.333 | PMID 26401278 Get It

Key Clinical MessageDistinguishing chronic lymphoproliferative disorder of NK‐cells from aggressive NK‐cell leukemia is critical because they have distinct clinical course and management. Immunophenotyping plays a key role in distinguishing these two entities, however, it could not be used as sole criteria and clinical/laboratory findings are equally important.
Streptococcus gordonii prosthetic joint infection in the setting of vigorous dental flossing
Klein, Rick, Dababneh, Ala S. , Palraj, Bharath Raj, Palraj, Raj , Palraj, Bharath Raj Varatharaj, Palraj, Raj

BMJ Case Reports | August 11, 2015 | Volume: 2015 | Issue: No issue available | Pages: bcr2015210695

10.1136/bcr-2015-210695 | PMID 26264944 Get It

A 65-year-old woman with osteoarthritis, who underwent knee replacement 5 years prior, developed sudden onset knee pain and swelling. She had voluntarily starting a vigorous dental flossing regimen prior to the onset of symptoms. The patient underwent right knee arthrotomy, irrigation and debridement of right total knee arthroplasty and exchange of polyethylene with retention of the prosthesis. Intraoperative cultures grew Streptococcus gordonii. She was treated with 6 weeks of ceftriaxone and was later placed on oral antibiotic suppression.
FGFR1 and FGFR2 in fibrolamellar carcinoma
Graham, Rondell P. , García, Joaquín J. , Greipp, Patricia T. , Kipp, Benjamin R. , Barr Fritcher, Emily G, Fritcher, Emily G. Barr , Torbenson, Michael , Graham, Rondell P , Greipp, Patricia T

Histopathology | August 11, 2015 | Volume: 68 | Issue: 5 | Pages: 686-692

10.1111/his.12799 | PMID 26259677 Get It

AimsFibrolamellar carcinoma is characterized by a recurrent DNAJB1–PRKACA chimeric transcript. The functional properties of the fusion are unknown, but are believed to include PRKACA up‐regulation. PRKCA is a subunit of protein kinase A. The downstream targets of protein kinase A are unknown, but may include interactions with fibroblast growth factor receptor (FGFR) pathways. In addition, inhibitors for FGFR proteins have been developed recently.Methods and resultsNineteen histologically confirmed fibrolamellar carcinomas were studied. All showed the characteristic DNAJB1–PRKACA transcript by reverse transcription–polymerase chain reaction (RT–PCR). Immunohistochemistry for FGFR1 was negative in 19 of 19 cases using a monoclonal antibody, while a polyclonal antibody showed no expression (n = 11) or weak and focal expression (n = 8). RNAin‐situ hybridization was 2+ in two cases, 1+ in four cases and negative in four cases. FGFR1 fluorescence in‐situ hybridization (FISH) revealed polysomy of chromosome 8 in 17 of 19 cases. Break‐apart FISH for FGFR2 was negative for rearrangements in 12 of 12 informative cases.ConclusionsFibrolamellar carcinomas show polysomy of chromosome 8 and the FGFR1 locus, and only modest mRNA expression and weak or absent expression at the protein level. FGFR2 rearrangement was not detected. These data reduce the likelihood that FGFR inhibitors will be effective in the treatment of most fibrolamellar carcinomas.
Reply to M. Gleeson et al
Nowakowski, Grzegorz S. , Macon, William R. , Gascoyne, Randy D. , Witzig, Thomas E.

Journal of Clinical Oncology | August 11, 2015 | Volume: 33 | Issue: 28 | Pages: 3216-3217

10.1200/jco.2015.61.8280 | PMID 26261258 Get It

2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium
Spitalnik, Steven L. , Triulzi, Darrell J., Devine, Dana V. , Dzik, Sunny , Eder, Anne F. , Gernsheimer, Terry , Kor, Daryl J. , Luban, Naomi L.C., Mondoro, Traci Heath, Welniak, Lisbeth A., Zou, Shimian , Glynn, Simone A. , Groups, for the State of the Science in Transfusion Medicine Working, Shaz, Beth H. , Spinella, Philip C. , Rogers, Mary A.M. , Vlaar, Alexander P. J. , Migliaccio, Anna Ritá , Callum, Jeannie , Karam, Oliver , Josephson, Cassandra D. , Roubinian, Nareg H. , Welniak, Lisbeth A., Groups, for the State of the Science in Transfusion Medicine Working, Devine, Dana V , Shaz, Beth H , Spinella, Philip C , Karam, Oliver

Transfusion | August 11, 2015 | Volume: 55 | Issue: 9 | Pages: 2282-2290

10.1111/trf.13250 | PMID 26260861 Get It

On March 25 and 26, 2015, the National Heart, Lung, and Blood Institute sponsored a meeting on the State of the Science in Transfusion Medicine on the National Institutes of Health (NIH) campus in Bethesda, Maryland, which was attended by a diverse group of 330 registrants. The meeting's goal was to identify important research questions that could be answered in the next 5 to 10 years and which would have the potential to transform the clinical practice of transfusion medicine. These questions could be addressed by basic, translational, and/or clinical research studies and were focused on four areas: the three “classical” transfusion products (i.e., red blood cells, platelets, and plasma) and blood donor issues. Before the meeting, four working groups, one for each area, prepared five major questions for discussion along with a list of five to 10 additional questions for consideration. At the meeting itself, all of these questions, and others, were discussed in keynote lectures, small‐group breakout sessions, and large‐group sessions with open discourse involving all meeting attendees. In addition to the final lists of questions, provided herein, the meeting attendees identified multiple overarching, cross‐cutting themes that addressed issues common to all four areas; the latter are also provided. It is anticipated that addressing these scientific priorities, with careful attention to the overarching themes, will inform funding priorities developed by the NIH and provide a solid research platform for transforming the future practice of transfusion medicine.
Genetics of Alzheimer's disease
Hutton, Michael , Hardy, John , Pérez‐Tur, Jordi , Hardy, John

Essays in Biochemistry | August 10, 2015 | Volume: 33 | Issue: No issue available | Pages: 117-131

10.1042/bse0330117 | PMID 10488446 Get It

CD38 is the major enzyme responsible for synthesis of nicotinic acid–adenine dinucleotide phosphate in mammalian tissues
Chini, Eduardo N. , Chini, Claudia C.S. , Kato, Ichiro, TAKASAWA, Shin, Okamoto, Hiroshi , Takasawa, Shin

Biochemical Journal | August 10, 2015 | Volume: 362 | Issue: 1 | Pages: 125-130

10.1042/bj3620125 Get It

In the present study, we have determined the role of the enzyme CD38 upon the synthesis of the Ca2+-releasing nucleotide nicotinic acid—adenine dinucleotide phosphate (NAADP). In rat tissues, we observed that the capacity for NAADP synthesis could be co-immunoprecipitated with CD38 using an anti-CD38 antibody. Furthermore, we observed that several tissues from CD38 knockout mice had no capacity for the synthesis of this nucleotide. In addition, CD38 was also identified as the major enzyme responsible for the synthesis of the second messenger cyclic ADP-ribose. These observations lead to the conclusion that CD38 is the major enzyme responsible for the synthesis of NAADP and cyclic ADP-ribose, and raises the possibility of a new signalling pathway where two different Ca2+-releasing nucleotides are synthesized by the same enzyme.